CRISPR THERAPEUTICS AG (CRSP) Operating income 2016–2025
CRISPR THERAPEUTICS AG (CRSP) annual operating income history from SEC filings — each fiscal year as reported.
-$664.6MFY2025 · since FY2016: -$68.1M → -$664.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$664.6M | -42.4% |
| FY2024 | -$466.6M | -109.7% |
| FY2023 | -$222.5M | +66.9% |
| FY2022 | -$673.2M | -280.2% |
| FY2021 | $373.5M | +205.4% |
| FY2020 | -$354.4M | -858.3% |
| FY2019 | $46.7M | +129.4% |
| FY2018 | -$158.9M | -145.9% |
| FY2017 | -$64.6M | +5.1% |
| FY2016 | -$68.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice